Krishna L, Dadparvar S, Brady L W, Micaily B, Meihofer M, Slizofski W J, Brown S J, Chevres A, Roman R, Khan A S
Department of Radiation Oncology and Nuclear Medicine, Hahnemann University, Philadelphia, PA 19102-1192.
J Nucl Med. 1993 Sep;34(9):1574-6.
We present the findings on iodine-131 (131I) scintigraphy, thallium-201 (201Tl) scintigraphy and quantitative thyroglobulin (QTG) estimation in two patients with follicular carcinoma of the thyroid with extensive metastases. The lesions were initially seen on 131I scintigraphs, but were not subsequently visualized with scanning doses of 131I (5 mCi), while retaining their ability to produce increasing amounts of thyroglobulin and take up 201Tl. Implications in choosing the appropriate diagnostic tests in the management of differentiated thyroid cancer are discussed.
我们报告了两例伴有广泛转移的甲状腺滤泡癌患者的碘-131(¹³¹I)闪烁扫描、铊-201(²⁰¹Tl)闪烁扫描及定量甲状腺球蛋白(QTG)评估结果。这些病变最初在¹³¹I闪烁扫描图上可见,但随后使用5毫居里的¹³¹I扫描剂量时未再显影,然而它们仍有能力产生越来越多的甲状腺球蛋白并摄取²⁰¹Tl。文中讨论了在分化型甲状腺癌管理中选择合适诊断测试的意义。